News
March 2018
Silver Santé Study features on French national TV programme
The Silver Santé Study has been featured in a high-profile French national TV news programme.
The TF1 programme, called ‘Le journal de 20h’, showed the work of the Silver Santé team at Cyceron and included an interview with Project Coordinator Dr Gaël Chételat in which she described the work being carried out by the project.
Dr Chételat said: “It was great to get the opportunity to highlight the work of the Silver Santé Study on such a high-profile television programme.”
“We are looking forward to sharing more about the project and its results once our clinical trials are completed and all the data has been analysed. Our aim, of course, is to learn more about what we can do to safeguard the mental health and wellbeing of the ageing population.”
The show was broadcast on 19th February on TF1.
The neuroimaging team at Cyceron were featured in the TF1 programme ’Le journal de 20h’.
New video showcases Silver Santé Study work and team
An exciting new video has been produced showcasing the Silver Santé Study’s work and research team.
The 3-minute long film – which features Project Coordinator Dr Gaël Chételat, some of our senior researchers, and Sujata Ray of Age UK – highlights the impact of poor mental health in later life and the difference that the Silver Santé Study aims to make to the lives of individuals as well as to Society as a whole.
Charlotte Reid, who managed production of the video on behalf of project partner Minerva Communications, said: “As an EU-funded project, it’s important that we keep EU citizens informed about our work and this short film is an easy and accessible way for people to find out what our project is about and how they personally may benefit from what is learned.”
“As well as posting the video on our website via YouTube, we will also be sharing it on social media so please help us spread the word by ‘liking’ and ‘sharing’ it as much as possible.”
To watch the video visit our YouTube Channel and to keep up to date with the latest on the Silver Santé Study sign up to our e-newsletter.
Clinical trials on course for success
Both Silver Santé clinical trials – Age Well and SCD Well – are progressing well and running on schedule.
Age Well, coordinated in Caen, France, is assessing the impact of various mental training techniques on healthy adults aged 65 plus as well as expert meditators. It has just completed its third and final wave of volunteer recruitment.
The SCD Well trial – taking place in the UK, Spain, France and Germany – is assessing the impact of mental training techniques on patients with subjective cognitive decline. Around 140 volunteers have now been recruited to take part in the trial.
In both trials, researchers are also investigating lifestyle factors such as sleep, diet and emotions to assess the role they play in maintaining good mental health and wellbeing as we age.
Keep up to date with the latest Silver Santé Study news by signing up to our e-newsletter.
Age Well volunteers taking part in a language lesson.
December 2017
Partners gather for annual consortium meeting in Barcelona
October 2017
Pilot study shows meditation may help cut Alzheimer’s risk
Play a vital role in improving mental health, urge Silver Santé team
Memory clinic patients recruited for next phase of four-centre clinical trial
June 2017
Volunteers help attract new recruits for Caen clinical trial
Trial investigating benefits of mental training techniques on memory clinic patients well underway
March 2017
Silver Sante Study nominated for SilverEco 2017 Award
Trial groups announced to Caen volunteers
December 2016
Hundreds volunteer to take part in Age-Well Study
Silver Santé Study partners gather for General Assembly in Bonn
Memory clinic patient trials due to begin in March 2017
September 2016
Silver Santé researchers meet with Dalai Lama
Volunteers in Caen, France, invited to local meetings
Preparations for further trials on course
June 2016
Huge turnout for 1st Public Conference
May 2016
You can also view official press releases and our e-newsletters.
And read ‘Points of View’ from our expert researchers.
